Form 4: OPKO Health CFO Adam Logal Reports Acquisition and Disposal of Common Stock

Sentiment:

SEC Form 4 Filing


Adam Logal, CFO of OPKO Health, reports acquiring 437,500 shares of common stock and disposing of an unspecified amount in a recent transaction.

Summary

  • On July 24, 2024, Adam Logal, the Senior Vice President and CFO of OPKO Health, Inc. reported a transaction involving the company's common stock.
  • Logal acquired 437,500 shares of common stock at a price of $0.00.
  • Following the reported transaction, Logal beneficially owns 616,662 shares of OPKO common stock.
  • The acquisition of shares was related to restricted stock units that vest over time.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock transactions by an executive, and does not inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

  • The transaction may have a minor impact on shareholders due to the change in ownership by a key executive.

Key Dates

DateDescription
07/24/2024Date of transaction involving acquisition and disposal of OPKO Health common stock.
07/26/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.